Essential medicines concept and health technology assessment approaches to prioritising medicines: selection versus incorporation

References

• IQVIA. Global use of medicines 2023: outlook to 2027. IQVIA Institute for Human Data Science. 2023.
   Google Scholar
• Saksena P, Xu K, Durairaj VThe drivers of catastrophic expenditure: outpatient services, hospitalization or medicines?2020GenevaWorld Health Organization
   Google Scholar
• Holloway K, van Dijk LThe World Medicines Situation 2011: Rational Use of Medicines2011GenevaWorld Health Organization
   Google Scholar
• WHO, Handbook of resolutions and decisions of the World Health Assembly and Executive Board, Vols. Vol. II 1973–1984, Geneva: World Health Organization, 1985, p. 129.
   Google Scholar
• van den Ham R, Bero L, Laing RThe world medicines situation 2011: selection of essential medicines2011GenevaWorld Health Organization
   Google Scholar
• Laing R, Waning B, Gray A, Ford N, t’Hoen E25 years of the WHO essential medicines lists: progress and challengesLancet2003361937017231729 10.1016/S0140-6736(03)13375-2 12767751
   PubMed Web of Science ®Google Scholar
• Wirtz V, Hogerzeil H, Gray A, Bigdeli M, de Joncheere C, Ewen M, et al.Essential medicines for universal health coverageLancet201738910067403476 10.1016/S0140-6736(16)31599-9 27832874
   PubMedGoogle Scholar
• World Health OrganizationRegional Office for Europe, “Medicines reimbursement policies in Europe”2018CopenhagenWorld Health Organization. Regional Office for Europe
   Google Scholar
• Stuart MC, Kouimtzi M, Hill SRWHO Model Formulary 20082009GenevaWorld Health Organization
   Google Scholar
• Reidenberg MMAre we moving towards a new definition of essential medicines?J Pharmacol Pharmacother201564233 10.4103/0976-500X.171874 26816479 4714396
   PubMedGoogle Scholar
• Standards and Regulation Division Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. Ministry of Health, Government of Jamaica, 2015.
   Google Scholar
• Ministry of Health Trinidad and Tobago. Pharmaceutical VEN Listing 2019. 2019. https://medlistapp.paho.org/en/list/28. Accessed 4 July 2023.
   Google Scholar
• Ministry of Health UgandaEssential Medicines and Health Supplies List for Uganda (EMHSLU)2016KampalaMInistry of Health Uganda
   Google Scholar
• Yuba TY, Novaes HM, de Soárez PCChallenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendationsHealth Res Policy Syst201816140 10.1186/s12961-018-0319-8 29751764 5948855
   PubMedGoogle Scholar
• Battista RN, Hodge MJThe “natural history” of health technology assessmentInt J Technol Assess Health Care200925S1281284 10.1017/S026646230909076X 19538817
   PubMedGoogle Scholar
• Taylor RS, Drummond MF, Salkeld G, Sullivan SDInclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdleBMJ20043297472972975 1:STN:280:DC%2BD2crislCnsw%3D%3D 10.1136/bmj.329.7472.972 15499118 524116
   PubMedGoogle Scholar
• Banta DWhat is technology assessment?Int J Technol Assess Health Care200925S179 10.1017/S0266462309090333 19519979
   PubMedGoogle Scholar
• WHO2015 Global Survey on Health Technology Assessment by National Authorities2015GenevaWorld Health Organization
   Google Scholar
• National Institute for Health and Clinical ExcellenceThe guidelines manual2012LondonNational Institute for Health and Clinical Excellence
   Google Scholar
• Kriza C, Hanass-Hancock J, Odame EA, et al.A systematic review of Health Technology Assessment tools in sub-Saharan Africa: methodological issues and implicationsHealth Res Policy Syst20141266 10.1186/1478-4505-12-66 25466570 4265527
   PubMed Web of Science ®Google Scholar
• Kularatna S, Whitty JA, Johnson NW, Scuffham PAHealth state valuation in low- and middle-income countries: a systematic review of the literatureValue Health201316610911099 10.1016/j.jval.2013.05.006 24041360
   PubMed Web of Science ®Google Scholar
• Mbondji PE, Kebede D, Soumbey-Alley EW, Zielinski C, Kouvividila W, Lusamba-Dikassa P-SResources, indicators, data management, dissemination and use in health information systems in sub-Saharan Africa: results of a questionnaire-based surveyJ R Soc Med2014107S12833 10.1177/0141076814528690 24739381 4109353
   PubMedGoogle Scholar
• Liu XPolicy tools for allocative efficiency of health services2003GenevaWorld Health Organization
   Google Scholar
• Grabowski H, Mullins CDPharmacy benefit management, cost-effectiveness analysis and drug formulary decisionsSoc Sci Med1997454535544 1:STN:280:DyaK2szntVCgsg%3D%3D 10.1016/S0277-9536(96)00394-2 9226779
   PubMed Web of Science ®Google Scholar
• Huskamp HA, Keating NLThe new medicare drug benefit: formularies and their potential effects on access to medicationsJ Gen Intern Med2005207662665 10.1007/s11606-005-0115-3 16050866 1403290
   PubMed Web of Science ®Google Scholar
• Avery AJ, Walker B, Heron T, Teasdale SJDo prescribing formularies help GPs prescribe from a narrower range of drugs? A controlled trial of the introduction of prescribing formularies for NSAIDsBr J Gen Pract199747425810814 1:STN:280:DyaK1c7isFWnsQ%3D%3D 9463982 1410088
   PubMed Web of Science ®Google Scholar
• Gustafsson L, Wettermark B, Godman B, Andersén-Karlsson E, Bergman U, Hasselström J, Hensjö L, Hjemdahl P, Jägre I, Julander M, Ringertz B, Schmidt D, Sjöberg S, Sjöqvist F, Stiller C, Törnqvist E, Tryselius R, Vitols S, von Bahr CThe 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in StockholmBasic Clin Pharmacol Toxicol20111084224233 1:CAS:528:DC%2BC3MXkslSkt7s%3D 10.1111/j.1742-7843.2011.00682.x 21414143
   PubMed Web of Science ®Google Scholar
• Ministry of Health, The United Republic of Tanzania. Standard Treatment Guidelines & National Essential Medicines List Tanzania Mainland. 2017.
   Google Scholar
• Banta D, Jonsson EHistory of HTA: IntroductionInt J Technol Assess Health Care200925S116 10.1017/S0266462309090321 19500432
   PubMedGoogle Scholar
• Noorani HZ, Husereau DR, Boudreau R, Skidmore BPriority setting for health technology assessments: a systematic review of current practical approachesInt J Technol Assess Health Care2007233310315 10.1017/S026646230707050X 17579932
   PubMed Web of Science ®Google Scholar
• Oliver A, Mossialos E, Robinson RHealth technology assessment and its influence on health-care priority settingInt J Technol Assess Health Care2004201110 10.1017/S026646230400073X 15176172
   PubMed Web of Science ®Google Scholar
• Kredo T, Bernhardsson S, Machingaidze S, Young T, Louw Q, Ochodo E, Grimmer KGuide to clinical practice guidelines: the current state of playInt J Qual Health Care2016281122128 10.1093/intqhc/mzv115 26796486 4767049
   PubMed Web of Science ®Google Scholar
• WHOAdditions and deletions of medicines on the WHO model lists of essential medicines: 1977–20172019GenevaWorld Health Organization
   Google Scholar
• Sermet C, Andrieu V, Godman B, Van Ganse E, Haycox A, Reynier J-POngoing pharmaceutical reforms in France: implications for key stakeholder groupsAppl Health Econ Health Policy201081724 10.1007/BF03256162 20038190
   PubMedGoogle Scholar
• Parkinson B, Sermet C, Clement F, Crausaz S, Godman B, Garner S, Choudhury M, Pearson S-A, Viney R, Lopert R, Elshaug AGDisinvestment and value-based purchasing strategies for pharmaceuticals: an international reviewPharmacoeconomics2015339905924 10.1007/s40273-015-0293-8 26048353
   PubMed Web of Science ®Google Scholar
• Guerra-Júnior AA, Pires de Lemos LLGB, Bennie M, Osorio-de-Castro CG, Alvares J, Heaney A, Vassallo CA, Wettermark B, Benguria-Arrate G, Gutierrez-Ibarluzea I, Santos V, Petramale C, Acurcio FHealth technology performance assessment: real-world evidence for public healthcare sustainabilityInt J Technol Assess Health Care2017332279287 10.1017/S0266462317000423 28641588
   PubMed Web of Science ®Google Scholar
• Ministério da Saúde, “Diretriz Metodológica de Avaliação de Desempenho de Tecnologias em Saúde: Desinvestimento e Reinvestimento,” Ministério da Saúde, Brasília, 2017.
   Google Scholar
• Garner S, Littlejohns PDisinvestment from low value clinical interventions: NICEly done?BMJ2011343 10.1136/bmj.d4519 21795239
   PubMedGoogle Scholar
• NICE. Technology appraisal recommendations (Excel document). 2023.
   Google Scholar
• Osorio-de-Castro CG, Azeredo TB, Pepe VL, Lopes LC, Sueli Y, Godman B, Gustafsson LLPolicy change and the national essential medicines list development process in Brazil between 2000 and 2014: has the essential medicine concept been abandoned?Basic Clin Pharmacol Toxicol20181224402412 1:CAS:528:DC%2BC2sXhvFWgsLrP 10.1111/bcpt.12932 29117642
   PubMed Web of Science ®Google Scholar
• CONITEC. CONITEC em números. Painel de acompanhamento de tecnologias em saúde submetidas à Conitec no Sistema Único de Saúde, CONITEC, 2023. https://lookerstudio.google.com/embed/reporting/ed1f017c-58e0-4177-aeb2-61f59d50b183/page/PzCbB. Accessed 27 Feb 2023.
   Google Scholar
• World Health Organization. Regional Office of Western Pacific, Conducive factors to the development of Health Technology Assessment in Asia. WHO Regional Office for the Western Pacific, 2015.
   Google Scholar
• MacQuilkan K, Baker P, Downey L, Ruiz F, Chalkidou K, Prinja S, Zhao K, Wilkinson T, Glassman A, Hofman KStrengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South AfricaGlob Health Action20181111527556 10.1080/16549716.2018.1527556 30326795 6197020
   PubMed Web of Science ®Google Scholar
• Natsis Y. The proposed European Commission Regulation on HTA: a golden opportunity for patients and health budgets. European public health alliance, 2018.
   Google Scholar
• Bazargani YT, Ewen M, de Boer A, Leufkens HG, Mantel-Teeuwisse AKEssential medicines are more available than other medicines around the globePLoS ONE201492 10.1371/journal.pone.0087576 24533058 3922716
   PubMed Web of Science ®Google Scholar
• Green A, Lyus R, Ocan M, Pollock AM, Brhlikova PRegistration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysisJ Royal Soc Med2023 10.1177/01410768231181263
   Web of Science ®Google Scholar